2005
DOI: 10.1016/j.bbr.2005.06.035
|View full text |Cite
|
Sign up to set email alerts
|

Opioid receptors modulate recovery from consummatory successive negative contrast

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
57
0
3

Year Published

2007
2007
2015
2015

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 55 publications
(63 citation statements)
references
References 28 publications
3
57
0
3
Order By: Relevance
“…A potential route of exploration involves treatments known to enhance these effects in mammals. For example, opioid receptor blockage with naloxone (a nonselective opioid receptor antagonist) and naltrindole (a delta-opioid receptor antagonist) has been shown to enhance cSNC in rats [34], [35]. Opioid receptors have been described in amphibians and are known to be homologous to those found in mammals [36], [37].…”
Section: Discussionmentioning
confidence: 99%
“…A potential route of exploration involves treatments known to enhance these effects in mammals. For example, opioid receptor blockage with naloxone (a nonselective opioid receptor antagonist) and naltrindole (a delta-opioid receptor antagonist) has been shown to enhance cSNC in rats [34], [35]. Opioid receptors have been described in amphibians and are known to be homologous to those found in mammals [36], [37].…”
Section: Discussionmentioning
confidence: 99%
“…For example, the nonselective opioid-receptor agonist morphine reduces the cSNC effect (Rowan and Flaherty, 1987), whereas the nonselective antagonist naloxone enhances the cSNC effect (Daniel et al, 2009;Pellegrini et al, 2005). Both of these effects are observed whether the drug is administered before the first or the second downshift session.…”
Section: Role Of Opioid and Cannabinoid Receptorsmentioning
confidence: 93%
“…Interestingly, selective opioid-receptor compounds can have effects on either the initial reaction to the downshift or after the animal has had some experience with the downshifted reward. For example, the delta opioid-receptor agonist DPDPE [d-Penicillamine(2,5)-enkephalin] and antagonist naltrindole reduced and enhanced the cSNC effect, respectively, when administered before the first downshift session, but had no effects when administered before the second downshift session (Pellegrini et al, 2005;Wood et al, 2005). Conversely, the kappa opioid-receptor agonist U50,488H modulates the cSNC effect when administered before the second downshift session, but has no effects when administered before the first downshift session (Wood et al, 2008).…”
Section: Role Of Opioid and Cannabinoid Receptorsmentioning
confidence: 98%
See 1 more Smart Citation
“…For example, Pellegrini et al [52] reported that the exploratory behavior of animals that recovered slowly from the downshift was more disrupted by the nonselective opioid-receptor antagonist naloxone than the behavior of animals that recovered relatively faster. Moreover, rats artificially selected for high recovery rates exhibited enhanced opioid receptor efficiency during reward downshift, attenuated emotional reactivity to partial reinforcement, and increased ultrasound vocalization to infant separation relative to low and random lines [40].…”
Section: Discussionmentioning
confidence: 99%